A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis

Allergan

Status and phase: Terminated; Phase 3; Phase 2

Conditions: Anterior Uveitis

Treatments: Drug: Dexamethasone

Study type: Interventional

Funder types: Industry

Identifiers

NCT00333996

206207-015

Details and patient eligibility

About

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious anterior uveitis.

Enrollment: 5 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years or older with a diagnosis of non-infectious anterior uveitis in at least one eye

Exclusion criteria

• Uncontrolled systemic disease
• Any active ocular infections

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind